609 related articles for article (PubMed ID: 16113044)
1. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome.
Eldar-Geva T; Ben-Chetrit A; Spitz IM; Rabinowitz R; Markowitz E; Mimoni T; Gal M; Zylber-Haran E; Margalioth EJ
Hum Reprod; 2005 Nov; 20(11):3178-83. PubMed ID: 16113044
[TBL] [Abstract][Full Text] [Related]
2. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
[TBL] [Abstract][Full Text] [Related]
3. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
[TBL] [Abstract][Full Text] [Related]
4. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
Muttukrishna S; Suharjono H; McGarrigle H; Sathanandan M
BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
[TBL] [Abstract][Full Text] [Related]
5. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation.
Yong PY; Baird DT; Thong KJ; McNeilly AS; Anderson RA
Hum Reprod; 2003 Jan; 18(1):35-44. PubMed ID: 12525438
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
McIlveen M; Skull JD; Ledger WL
Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
[TBL] [Abstract][Full Text] [Related]
7. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of some ovarian reserve tests in poor responders.
Vladimirov IK; Tacheva DM; Kalinov KB; Ivanova AV; Blagoeva VD
Arch Gynecol Obstet; 2005 Jun; 272(1):74-9. PubMed ID: 15660265
[TBL] [Abstract][Full Text] [Related]
9. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
[TBL] [Abstract][Full Text] [Related]
10. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.
Fanchin R; Schonäuer LM; Righini C; Guibourdenche J; Frydman R; Taieb J
Hum Reprod; 2003 Feb; 18(2):323-7. PubMed ID: 12571168
[TBL] [Abstract][Full Text] [Related]
11. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
12. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
[TBL] [Abstract][Full Text] [Related]
13. Interactions between serum FSH, inhibin B and antral follicle count in the decline of serum AMH during the menstrual cycle in late reproductive age.
Robertson DM; Lee CH; Baerwald A
Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00172. PubMed ID: 33855196
[TBL] [Abstract][Full Text] [Related]
14. Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition.
van Rooij IA; Tonkelaar Id; Broekmans FJ; Looman CW; Scheffer GJ; de Jong FH; Themmen AP; te Velde ER
Menopause; 2004; 11(6 Pt 1):601-6. PubMed ID: 15545787
[TBL] [Abstract][Full Text] [Related]
15. Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.
Cupisti S; Dittrich R; Mueller A; Strick R; Stiegler E; Binder H; Beckmann MW; Strissel P
Eur J Med Res; 2007 Dec; 12(12):604-8. PubMed ID: 18024272
[TBL] [Abstract][Full Text] [Related]
16. Anti-mullerian hormone as a marker of ovarian reserve.
Tremellen KP; Kolo M; Gilmore A; Lekamge DN
Aust N Z J Obstet Gynaecol; 2005 Feb; 45(1):20-4. PubMed ID: 15730360
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases.
van den Berg MH; van Dulmen-den Broeder E; Overbeek A; Twisk JW; Schats R; van Leeuwen FE; Kaspers GJ; Lambalk CB
Hum Reprod; 2010 Jun; 25(6):1520-7. PubMed ID: 20348556
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
[TBL] [Abstract][Full Text] [Related]
19. Early follicular antimüllerian hormone as an indicator of ovarian reserve.
Fiçicioglu C; Kutlu T; Baglam E; Bakacak Z
Fertil Steril; 2006 Mar; 85(3):592-6. PubMed ID: 16500324
[TBL] [Abstract][Full Text] [Related]
20. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
